Clinical Trials on Doenças ósseas de desenvolvimento
Total 0 results
Nothing found
Sponsors and Collaborators
- MingSight Pharmaceuticals Pty Limited
- Jeffrey W. Clark, MD
- Health Parametrics Inc.
- Zahra Rabbani Khah
- European Network For Smoking and Tobacco Prevention
- The Third Hospital of Changsha
- Kawin Technology Share-holding Co., Ltd.
- New York State Health Foundation
- Montreal Neurological Institute and Hospital
- Northern California Melanoma Center
- Honda R and D Americas, Inc.
- Rex Bionics Plc
- Marilia Medicine School
- Medtronic Atrial Fibrillation Solutions
- Mitchell Scheiman
- Ionis Pharmaceuticals
- John Granton
- CTC Bio, Inc.
- Jeffrey Rudolph
- Wushan County People's Hospital
- View Full List
Medical Conditions
- Helicobacter Pylori 23S rRNA Clarithromycin Resistance Mutation
- Locally Advanced NSCLC
- Brain MRI
- Consequences for Nursing Home Residents and Staff of Integrating Reminiscence Into Daily Nursing Care.
- ACTH-Secreting Pituitary Adenoma
- Pancreatic Neoplasms
- Periferal Arterial Occlusive Disease, PAOD
- Waldenstrom's Macroglobulinemia Recurrent
- Primary Generalized Dystonia
- H.Pylori Infection
- LSIL
- Advanced Esophageal Cancers
- Fasting, Diet, Chemotherapy, Toxicity
- Pregnancy-Related Condition, Unspecified
- Ascaris Suum
- Liver Hemangioma
- Hyperthyroidism, Autoimmune
- Metastatic Spine Lesions
- Renal Cancer Metastatic
- HDT-AHCT
- View Full List
Drug Interventions
- Irinotecan, capecitabine, oxaliplatin (IXO) and bevacizumab
- CKD-519
- ESK981
- Cyclophosphamide, Hydroxydaunorubicin, Oncovin, Prednisone/Prednisolone (CHOP)
- Levcromakalim
- Up-and-down method to find out effective concentration of remifentanil for preventing cough during emergence
- 5-Fluoro-3-Pyridinecarboxylic Acid
- Levobupivacaine, clonidine
- Pentostatin
- Rifaximin
- Toripalimab plus Anlotinib
- Postoperative analgesia management
- Nimotuzumab
- Ombrabulin (AVE8062)
- Hydroxychloroquine
- AZD7798
- Fludarabine
- 200 µg doxorubicin-containing MNA
- Bendamustine
- Tenofovir disoproxil fumarate (TDF) 300mg co-formulated with emtricitabine (FTC 200mg) once daily oral administration
- View Full List
CROs by country
- Contract Research Organizations in Azerbaijan
- Contract Research Organizations in Belarus
- Contract Research Organizations in Belgium
- Contract Research Organizations in Croatia
- Contract Research Organizations in Equatorial Guinea
- Contract Research Organizations in Gabon
- Contract Research Organizations in Kyrgyzstan
- Contract Research Organizations in Malawi
- Contract Research Organizations in Mexico
- Contract Research Organizations in Moldova
- Contract Research Organizations in Norway
- Contract Research Organizations in South Africa
- Contract Research Organizations in Turkmenistan
- CRO list by country